MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 161 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,909,571 | +24.1% | 6,816 | +18.3% | 0.07% | +18.3% |
| Q1 2024 | $1,538,952 | -7.1% | 5,763 | -19.5% | 0.06% | -15.5% |
| Q4 2023 | $1,656,681 | +46.9% | 7,160 | -7.3% | 0.07% | +14.5% |
| Q3 2023 | $1,127,867 | -16.2% | 7,723 | +32.6% | 0.06% | -13.9% |
| Q2 2023 | $1,345,575 | +3.5% | 5,825 | +8.6% | 0.07% | -10.0% |
| Q1 2023 | $1,299,967 | +295.3% | 5,366 | +373.6% | 0.08% | +281.0% |
| Q4 2022 | $328,853 | +59.6% | 1,133 | -38.1% | 0.02% | +61.5% |
| Q4 2018 | $206,000 | -45.4% | 1,829 | +3.8% | 0.01% | -7.1% |
| Q3 2018 | $377,000 | – | 1,762 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paulson & Co. | 1,850,000 | $518,296,000 | 38.31% |
| Tao Capital Management LP | 130,529 | $36,569,005 | 29.98% |
| University of Wisconsin Foundation | 45,730 | $12,811,717 | 14.42% |
| AlpInvest Partners B.V. | 84,595 | $23,700,135 | 8.50% |
| RTW INVESTMENTS, LP | 1,915,862 | $536,747,898 | 8.31% |
| Propel Bio Management, LLC | 43,032 | $12,055,845 | 7.82% |
| Avoro Capital Advisors LLC | 2,055,555 | $575,884,289 | 7.67% |
| Baker Brothers Advisors | 1,974,590 | $553,201,134 | 7.07% |
| Tri Locum Partners LP | 65,352 | $18,309,016 | 4.63% |
| TCG Crossover Management, LLC | 149,283 | $41,823,125 | 4.36% |